Zenith Capital Corporation

Equities

ZENI.P

CA98936P1071

Biotechnology & Medical Research

Market Closed - Toronto S.E. Other stock markets 16:00:00 16/04/2024 BST			5-day change	1st Jan Change
0.105 ^CAD	-.--%		-.--%	-.--%

03-28	Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
2023	Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2023	CI

Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022

March 28, 2022 at 07:51 pm

Zenith Capital Corporation reported earnings results for the second quarter and six months ended January 31, 2022. For the second quarter, the company reported net loss was CAD 0.047122 million compared to CAD 0.006902 million a year ago.
For the six months, net loss was CAD 0.103345 million compared to CAD 0.021843 million a year ago.

Latest news about Zenith Capital Corporation

Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	03-28	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2023	11-27	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	14/06/23	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	28/03/23	CI
Grand Samsara Consulting LLC and CBGB Ventures Corp. signed a binding letter agreement to acquire Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction.	19/03/23	CI
Zenith Capital Corporation announced that it expects to receive CAD 1 million in funding from Grand Samsara Consulting LLC	07/03/23	CI
Zenith Capital Corporation announced that it has received CAD 0.2 million in funding	22/02/23	CI
Zenith Capital Corporation announced that it expects to receive CAD 0.2 million in funding	14/02/23	CI
Venda Robotix Ltd cancelled the acquisition of Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction..	22/01/23	CI
Zenith Capital Corporation Reports Earnings Results for the First Quarter Ended October 31, 2022	08/12/22	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2022	16/11/22	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	21/06/22	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	28/03/22	CI
Zenith Capital Corporation Reports Earnings Results for the First Quarter Ended October 31, 2021	29/11/21	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2021	08/11/21	CI
Zenith Capital Corporation Auditor Raises 'Going Concern' Doubt	07/11/21	CI
Venda Robotix Ltd entered into a binding letter of intent to acquire Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction.	17/08/21	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter Ended April 30, 2021	02/06/21	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter Ended January 31, 2021	05/03/21	CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2020	15/10/20	CI
Zenith Capital Corporation Auditor Raises 'Going Concern' Doubt	14/10/20	CI
Zenith Capital Corporation announced that it has received $2.000001 million in funding	15/06/20	CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter Ended April 30, 2020	08/06/20	CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter Ended January 31, 2020	10/03/20	CI
Zenith Capital Corporation has completed an IPO in the amount of CAD 0.2 million.	06/03/20	CI

Chart Zenith Capital Corporation

Duration

Period

More charts

Company Profile

Zenith Capital Corporation is a Canada-based capital pool company. The principal activity of the Company is the identification and evaluation of assets or a business and, once identified or evaluated, to negotiate an acquisition of, or participation in, a business subject to receipt of shareholders approval, if required, and acceptance by regulatory authorities (the Qualifying Transaction). The Company has not identified a business or asset that warrants acquisition or participation.

Sector

Biotechnology & Medical Research

Calendar

10/06/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
ZENITH CAPITAL CORPORATION	-.--%	325K
MODERNA, INC.	+29.77%	49.46B
IQVIA HOLDINGS INC.	+1.00%	42.58B
LONZA GROUP AG	+50.13%	42.49B
CELLTRION, INC.	-5.26%	29.09B
ICON PUBLIC LIMITED COMPANY	+13.68%	26.61B
ALNYLAM PHARMACEUTICALS, INC.	-22.99%	18.64B
BIO-TECHNE CORPORATION	+8.22%	13.16B
MEDPACE HOLDINGS, INC.	+32.41%	12.55B
UNITED THERAPEUTICS CORPORATION	+24.01%	12.1B

Other Biotechnology & Medical Research